Log in to save to my catalogue

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-...

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7186849

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer

About this item

Full title

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer

Publisher

London: Future Medicine Ltd

Journal title

Lung cancer management, 2020-06, Vol.9 (2)

Language

English

Formats

Publication information

Publisher

London: Future Medicine Ltd

More information

Scope and Contents

Contents

Among the 16 trials evaluated, the authors found a statistically significant difference in reduction of risk of mortality between patients with high BMI and patients with low BMI. [...]PFS and objective response rate in cancer patients with high BMI were improved, and the prognostic role of BMI was independent of sex. [...]obesity is basically asso...

Alternative Titles

Full title

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7186849

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7186849

Other Identifiers

ISSN

1758-1966

E-ISSN

1758-1974

DOI

10.2217/lmt-2019-0016

How to access this item